Ascendis raises $120M in follow-on

Ascendis Pharma A/S (NASDAQ:ASND) raised $120 million through the sale of 6.3 million ADSs at $19 in a follow-on underwritten by JPMorgan, BofA Merrill Lynch, Credit Suisse and Wedbush. The company proposed the offering after market hours Tuesday, when it closed at $20.09. Ascendis shed $1.09 to $19 on Wednesday. ...